Cargando…

Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma

Fremanezumab, one of the anti-calcitonin gene-related peptide monoclonal antibodies, is widely used for migraine prophylaxis. However, its efficacy for headache attributed to glioblastoma has not been reported. We herein report a 66-year-old man who had right temporoparietal glioblastoma which recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Shin, Katsuki, Masahito, Kashiwagi, Kenta, Koh, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637455/
https://www.ncbi.nlm.nih.gov/pubmed/36381868
http://dx.doi.org/10.7759/cureus.30064
_version_ 1784825191450279936
author Kawamura, Shin
Katsuki, Masahito
Kashiwagi, Kenta
Koh, Akihito
author_facet Kawamura, Shin
Katsuki, Masahito
Kashiwagi, Kenta
Koh, Akihito
author_sort Kawamura, Shin
collection PubMed
description Fremanezumab, one of the anti-calcitonin gene-related peptide monoclonal antibodies, is widely used for migraine prophylaxis. However, its efficacy for headache attributed to glioblastoma has not been reported. We herein report a 66-year-old man who had right temporoparietal glioblastoma which recurred despite surgical and chemo-radiological treatment. He had migraine and headache attributed to glioblastoma, but fremanezumab improved both of them. Our case suggested that fremanezumab’s possible efficacy for not only migraine but also headache attributed to intracranial neoplasia.
format Online
Article
Text
id pubmed-9637455
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-96374552022-11-14 Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma Kawamura, Shin Katsuki, Masahito Kashiwagi, Kenta Koh, Akihito Cureus Pain Management Fremanezumab, one of the anti-calcitonin gene-related peptide monoclonal antibodies, is widely used for migraine prophylaxis. However, its efficacy for headache attributed to glioblastoma has not been reported. We herein report a 66-year-old man who had right temporoparietal glioblastoma which recurred despite surgical and chemo-radiological treatment. He had migraine and headache attributed to glioblastoma, but fremanezumab improved both of them. Our case suggested that fremanezumab’s possible efficacy for not only migraine but also headache attributed to intracranial neoplasia. Cureus 2022-10-08 /pmc/articles/PMC9637455/ /pubmed/36381868 http://dx.doi.org/10.7759/cureus.30064 Text en Copyright © 2022, Kawamura et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pain Management
Kawamura, Shin
Katsuki, Masahito
Kashiwagi, Kenta
Koh, Akihito
Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
title Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
title_full Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
title_fullStr Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
title_full_unstemmed Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
title_short Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
title_sort fremanezumab improved migraine and headache attributed to glioblastoma
topic Pain Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637455/
https://www.ncbi.nlm.nih.gov/pubmed/36381868
http://dx.doi.org/10.7759/cureus.30064
work_keys_str_mv AT kawamurashin fremanezumabimprovedmigraineandheadacheattributedtoglioblastoma
AT katsukimasahito fremanezumabimprovedmigraineandheadacheattributedtoglioblastoma
AT kashiwagikenta fremanezumabimprovedmigraineandheadacheattributedtoglioblastoma
AT kohakihito fremanezumabimprovedmigraineandheadacheattributedtoglioblastoma